LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death

Gliomas are aggressive brain tumors with very high resistance to chemotherapy throughout the overexpression of multiple intracellular survival pathways. Therefore, the aim of the present study was to investigate for the first time the anticancer activity of LY294002, phosphatidylinositol 3-kinase (P...

Descripción completa

Detalles Bibliográficos
Autores principales: A, Zając, J, Sumorek-Wiadro, A, Maciejczyk, E, Langner, I, Wertel, W, Rzeski, J, Jakubowicz-Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526469/
https://www.ncbi.nlm.nih.gov/pubmed/34236519
http://dx.doi.org/10.1007/s00441-021-03481-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526469/
https://www.ncbi.nlm.nih.gov/pubmed/34236519
http://dx.doi.org/10.1007/s00441-021-03481-0

Ejemplares similares